company

Alkermes, Inc.

as of 2026-07-01
Monitor thisAsk about this
at a glance
23 trials sponsored · 18 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

18 assets
AripiprazoleOlanzapinePaliperidoneAL-NCDALK3831ALKS 3831ALKS 9072ALKS 9072, HighALKS 9072, High DoseALKS 9072, LowALKS 9072, Low DoseALKS 9072, Med doseARI-ORALComputerized cognitive and functional skills trainingOLZ/SAMSamidorphan (High Dose)Samidorphan (Low Dose)Samidorphan (Medium Dose)

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Aripiprazole
small molecule
drug
Olanzapine
small molecule
drug
Paliperidone
small molecule
drug
AL-NCD
small molecule
drug
ALK3831
small molecule
drug
ALKS 3831
small molecule
drug
ALKS 9072
small molecule
drug
ALKS 9072, High
small molecule
drug